Frazier Life Sciences Appoints Gordon Empey as Chief Operating Officer

News

Frazier Life Sciences Appoints Gordon Empey as Chief Operating Officer

2025-05-01 19:59 Last Updated At：20:20

PALO ALTO, Calif.--(BUSINESS WIRE)--May 1, 2025--

Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the appointment of Gordon Empey as Chief Operating Officer (COO). Gordon, who brings more than 25 years of experience advising venture capital investors and life sciences companies, will continue in his roles as Partner and General Counsel alongside his new responsibilities as COO.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250501881820/en/

In his expanded role, Gordon will oversee FLS’ enterprise functions, including legal, investor relations, operations, compliance, human resources, and information technology, while working closely with the investment and finance teams to align business operations with the firm’s strategic goals.

“Gordon has played an important role in FLS’ strategic expansion, contributing to the development of our long-only public fund strategy and the launch of FLS Public Funds,” said Patrick Heron, Managing Partner at FLS. “His appointment is a natural progression from his impactful leadership as Partner and General Counsel, where he has helped position the firm for sustained success and growth. We are excited for him to take on this expanded role.”

Since joining FLS in 2017, Gordon has served as General Counsel and Partner on the Life Sciences team, supporting the firm’s continued growth through its venture funds, including Frazier Life Sciences IX, L.P. ($419M), Frazier Life Sciences X, L.P. ($617M), and Frazier Life Sciences XI, L.P. ($987M). In his role, he has led investment structuring efforts, supported company formation activities, and advised numerous life sciences venture firms and portfolio companies on corporate strategy and transactions. Gordon also played a key role in the formation and launch of the FLS-sponsored SPAC, Frazier Lifesciences Acquisition Corporation, where he served as Vice President and General Counsel.

“It has been a privilege to work alongside the entire Frazier Life Sciences team and to contribute to the firm’s evolution during a period of meaningful growth,” said Gordon Empey, COO, Partner and General Counsel at FLS. “I look forward to continuing to support the firm’s efforts to build transformative companies that can have a significant impact on patients’ lives.”

Prior to joining FLS, Gordon was a Partner with Cooley LLP, one of the leading biotechnology and technology law firms. Before joining Cooley LLP, Gordon was Executive Vice President and General Counsel at Radiant Research. Early in his career, he served as an officer in the United States Navy, Judge Advocate General Corps. Gordon holds a J.D. from the University of California at Berkeley School of Law and graduated with High Honors in History, magna cum laude from Colgate University.

About Frazier Life Sciences

Frazier Life Sciences invests globally in private and publicly traded companies that discover, develop, and commercialize innovative biopharmaceuticals. Frazier Life Sciences manages over $3.9 billion in capital, including Venture Funds focusing on company creation and private companies and the long-only Public Funds focused on small and mid-cap public companies. Since 2005, over 60 Frazier Life Sciences portfolio companies, many of which were created or seeded by FLS, have completed IPOs or M&As. The Frazier Life Sciences team consists of over 40 professionals in biopharmaceuticals, primarily located in Palo Alto, Calif. (headquarters), San Diego, Seattle, Boston, New York, and London.

For more information about Frazier Life Sciences, please visit frazierls.com and follow us on LinkedIn.

The Golden Globes are tonight. Here's what to look for and how to watch and stream the show

The Golden Globes bill themselves as Hollywood’s booziest bash. This year, is anyone ready to party?

Political tension and industrywide uncertainty are the prevailing moods heading into Sunday night's 83rd Golden Globes. Hollywood is coming off a disappointing box-office year and now anxiously awaits the fate of one of its most storied studios, Warner Bros.

A celebratory mood might be even more elusive given that the wide majority of the performers and filmmakers congregating at the Beverly Hilton in Beverly Hills, California, oppose the policies of President Donald Trump. Likely to be on the minds of many attendees: the recent U.S. involvement in Venezuela and the fatal shooting of 37-year-old mother Renee Good in Minneapolis by Immigration and Customs Enforcement.

But through their ups and downs, the Globes have always tried to put pomp over politics. Host Nikki Glaser has vowed as much.

“You’d be surprised that half the room had no clue why I was saying ‘Venezuela,’” Glaser told The Associated Press earlier in the week, referring to her comedy-club warm-ups. “People aren’t getting the news like we all are.”

Glaser, a comic known for her roast appearances, has promised to go after A-listers in her second time hosting.

“We’re going to hit Leo,” Glaser said. “The icebergs are coming.”

Here’s what to look for at this year’s Globes:

The Golden Globes kick off at 8 p.m. EST on CBS while streaming live for Paramount+ premium subscribers. E!’s red carpet coverage begins at 6 p.m. EST.

The Associated Press will be have a livestream show beginning at 4:30 p.m. Eastern with a mix of stars' arrivals, fashion shots and celebrity interviews. It will be available on YouTube and APNews.

The overwhelming Oscar favorite “One Battle After Another” comes in with a leading nine nominations. It’s competing in the Globes’ musical or comedy category, which means the drama side might be more competitive. There, Ryan Coogler’s “Sinners,” Chloé Zhao’s “Hamnet” and Joachim Trier’s “Sentimental Value” are all in the mix.

But thus far, “One Battle After Another” has cleaned up just about everywhere. Much of Paul Thomas Anderson’s cast is nominated, including DiCaprio, Teyana Taylor, Sean Penn, Chase Infiniti and Benicio Del Toro.

If it and “Sinners” take home the two biggest prizes, it will be a banner night for Warner Bros. even as its future hangs in the balance. The studio has agreed to be acquired by Netflix is a deal worth $82.7 billion. Movie theaters have warned such a result would be “a direct and irreversible negative impact on movie theaters around the world.”

The merger awaits regulatory approval, while Paramount Skydance is still trying to convince Warner shareholders to accept its rival offer.

After an audacious promotional tour for “Marty Supreme,” Timothée Chalamet is poised to win his first Globe in five nominations. In best actor, comedy or musical, he’ll have to beat DiCaprio, a three-time Globe winner, and Ethan Hawke (“Blue Moon”).

In best actress, comedy or musical, Rose Byrne is the favorite for her performance in the not especially funny A24 indie “If I Had Legs I’d Kick You.” One prominent nominee in the category, Cynthia Erivo (“Wicked: For Good”), won’t be attending due to her schedule in the West End production “Dracula.”

Jessie Buckley (“Hamnet”) is the clear front-runner in best actress, drama. In the star-studded best actor, drama, category, the Brazilian actor Wagner Moura (“The Secret Agent”) may win over Michael B. Jordan (“Sinners”) and Joel Edgerton (“Train Dreams”).

In the supporting categories, Teyana Taylor and Stellan Skarsgård come in the favorites.

The Globes, formerly presented by the Hollywood Foreign Press Association, have no overlap or direct correlation with the Academy Awards. After being sold in 2023 to Todd Boehly’s Eldridge Industries and Dick Clark Productions, a part of Penske Media, the Globes are voted on by around 400 people. The Oscars are voted on by more than 10,500 professionals.

But in the fluctuating undulations of awards season, a good speech at the Globes can really boost an Oscar campaign. Last year, that seemed to be the case for Demi Moore, who won for “The Substance” and gave the night's most emotional speech. Mikey Madison (“Anora”), however, scored the upset win at the Oscars.

A few potentially good moments this year went instead in a Golden Eve ceremony earlier this week. There, the Cecil B. DeMille and Carol Burnett honorees, Helen Mirren and Sarah Jessica Parker, accepted their awards.

One to watch, if he wins, will be the Iranian director Jafar Panahi. His revenge drama “It Was Just an Accident” is up for four awards. Panahi has spent most of his career making films clandestinely, without approval of authorities, and was until recently banned from leaving the country. Last month, he was sentenced to a year in prison, which would be only his latest stint behind bars if Panahi returns home to serve it. This week, protests over Iran’s ailing economy have spread throughout the country in a new test to Iran's leaders.

For the first time, the Globes are trotting out a new podcast category. The nominees are: “Armchair Expert,” “Call Her Daddy,” “Good Hang With Amy Poehler,” “The Mel Robbins Podcast,” “SmartLess” and “Up First.”

In TV, HBO Max’s “The White Lotus” — another potential big winner for Warner Bros. — leads with six nominations. Netflix’s “Adolescence” comes in with five nods.

But the most closely watched nominee might be “The Studio.” The first season of Seth Rogen’s Hollywood satire memorably included an episode devoted to drama around a night at the Globes. (Sample line: “I remember when the red carpet of the Golden Globes actually stood for something.”) “The Studio” is up for three awards, giving three chances for life to imitate art.

For more coverage of this year’s Golden Globe Awards, visit: https://apnews.com/hub/golden-globe-awards